Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 21
Newsletter articlesFull Text
Millennium announces phase II data for MLN02
Publisher:NewsRX LLC
Journal title:Biotech Week, 2002, p.60
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 22
Newsletter articlesFull Text
Millennium Pharmaceuticals, Inc.; Study: MLN02 produced significant improvement
Publisher:Atlanta: NewsRx
Journal title:Biotech Week, 2003, p.306
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 23
Newsletter articlesFull Text
Millennium Pharmaceuticals, Inc.; Millennium announces phase II data for MLN02
Publisher:Atlanta: NewsRx
Journal title:Biotech Week, 2002, p.60
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 24
Newsletter articlesFull Text
Millennium Announces Phase II Data for MLN02 in Crohn's Disease
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2002, p.1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 25
Newsletter articlesFull Text
In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2003, p.1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 26
Newsletter articlesFull Text
New England Journal of Medicine Publishes Studies of VELCADE(R) (bortezomib) for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2005, p.1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 27
Newspaper ArticlesFull Text
New England Journal of Medicine Publishes Studies of VELCADE for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis
Publisher:PR Newswire Association LLC
Journal title:PR newswire, 2005-06-16
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 28
Newspaper ArticlesFull Text
In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo; -- Novel Monoclonal Antibody Was Well Tolerated...
Publisher:PR Newswire Association LLC
Journal title:PR newswire, 2003-05-21
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 29
ArticlesPeer ReviewedFull Text
Treatment of Ulcerative Colitis with a Humanized Antibody to the α4β7 Integrin
Author / Creator:Feagan, Brian G ; Greenberg, Gordon R ; Wild, Gary ; Fedorak, Richard N ; Paré, Pierre ; McDonald, John W.D ; Dubé, Rejean ; Cohen, Albert ; Steinhart, A. Hillary ; Landau, Steven ; Aguzzi, Rasha A ; Fox, Irving H ; Vandervoort, Margaret K
Publisher:Boston, MA: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2005-06, Vol.352 (24), p.2499-2507
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 30
ArticlesPeer ReviewedFull Text
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
Author / Creator:Feagan, Brian G ; Greenberg, Gordon R ; Wild, Gary ; Fedorak, Richard N ; Paré, Pierre ; McDonald, John W D ; Dubé, Rejean ; Cohen, Albert ; Steinhart, A Hillary ; Landau, Steven ; Aguzzi, Rasha A ; Fox, Irving H ; Vandervoort, Margaret K
Publisher:United States
Journal title:The New England journal of medicine, 2005-06, Vol.352 (24), p.2499-2507
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 31
ArticlesPeer ReviewedFull Text
Treatment of Ulcerative Colitis with a Humanized Antibody to the [alpha]^sub 4^[beta]^sub 7^ Integrin
Author / Creator:Feagan, Brian G ; Greenberg, Gordon R ; Wild, Gary ; Fedorak, Richard N ; Paré, Pierre ; McDonald, John WD ; Dubé, Rejean ; Cohen, Albert ; Steinhart, A Hillary ; Landau, Steven ; Aguzzi, Rasha A ; Fox, Irving H ; Vandervoort, Margaret K
Publisher:Boston: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2005-06, Vol.352 (24), p.2499
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 32
ArticlesPeer ReviewedFull Text
Treatment of Ulcerative Colitis with a Humanized Antibody to the alpha sub(4) beta sub(7) Integrin
Author / Creator:Feagan, B G ; Greenberg, G R ; Wild, G ; Fedorak, R N ; Pare, P ; McDonald, JWD ; Dube, R ; Cohen, A ; Steinhart, AH ; Landau, S ; Aguzzi, R A ; Fox, I H ; Vandervoort, M K
Journal title:The New England journal of medicine, 2005-06, Vol.352 (24), p.2499-2507
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 33
ArticlesPeer ReviewedFull Text
Long-term clinical experience with Vedolizumab in patients with mild to moderate Ulcerative Colitis
Author / Creator:Parikh, Asit ; Leach, Timothy ; Xu, Jing ; Feagan, Brian
Publisher:Oxford, UK: Oxford University Press
Journal title:Inflammatory bowel diseases, 2011-12, Vol.17 (Suppl_2), p.S23-S23
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 34
ArticlesPeer ReviewedFull Text
Advances in biologic therapy for ulcerative colitis and Crohn's disease
Author / Creator:D'Haens, Geert ; Daperno, Marco
Publisher:United States: Springer Nature B.V
Journal title:Current gastroenterology reports, 2006-12, Vol.8 (6), p.506-512
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 35
ArticlesPeer ReviewedFull Text
Exclusive antagonism of the [alpha]4[beta]7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
Author / Creator:Fedyk, Eric R ; Wyant, Tim ; Yang, Li-Li ; Csizmadia, Vilmos ; Burke, Kristine ; Yang, Hua ; Kadambi, Vivek J
Publisher:Baltimore: Oxford University Press
Journal title:Inflammatory bowel diseases, 2012-11, Vol.18 (11), p.2107
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 36
ArticlesPeer ReviewedFull Text
Antibody to [alpha]^sub 4^[beta]^sub 7^ Integrin for Ulcerative Colitis/THE AUTHORS AND A COLLEAGUE REPLY
Author / Creator:Danese, Silvio ; Sarah A De La Rue ; Gasbarrini, Antonio ; Feagan, Brian G
Publisher:Boston: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2005-09, Vol.353 (11), p.1180
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 37
ArticlesPeer ReviewedFull Text
Evolving knowledge and therapy of inflammatory bowel disease
Author / Creator:Korzenik, Joshua R. ; Podolsky, Daniel K.
Publisher:London: Nature Publishing Group UK
Journal title:Nature reviews. Drug discovery, 2006-03, Vol.5 (3), p.197-209
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 38
ArticlesPeer ReviewedFull Text
Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers
Author / Creator:Milch, Catherine ; Wyant, Tim ; Xu, Jing ; Kent, Whitney ; Berger, Joseph ; Fox, Irving
Publisher:Oxford, UK: Oxford University Press
Journal title:Inflammatory bowel diseases, 2011-12, Vol.17 (Suppl_2), p.S54-S54
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 39
ArticlesPeer ReviewedFull Text
Internalization of the vedolizumab/α4β7 complex and kinetics of restoring functional activity
Author / Creator:Yang, Li-Li ; Fedyk, Eric ; Wyant, Tim
Publisher:Oxford, UK: Oxford University Press
Journal title:Inflammatory bowel diseases, 2011-12, Vol.17 (Suppl_2), p.S82-S83
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 40
ArticlesPeer ReviewedFull Text
Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers: P-136
Author / Creator:Milch, Catherine ; Wyant, Tim ; Xu, Jing ; Kent, Whitney ; Berger, Joseph ; Fox, Irving
Publisher:Baltimore: Oxford University Press
Journal title:Inflammatory bowel diseases, 2011-12, Vol.17, p.S54-S54
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 21 to 40 of 35 results

Search the collection

Export record to excel

Export this record

Export record to excel

Millennium announces phase II data for MLN02

Export this record

Export record to excel

Millennium Pharmaceuticals, Inc.; Study: MLN02 produced significant improvement

Export this record

Export record to excel

Millennium Pharmaceuticals, Inc.; Millennium announces phase II data for MLN02

Export this record

Export record to excel

Millennium Announces Phase II Data for MLN02 in Crohn's Disease

Export this record

Export record to excel

In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo

Export this record

Export record to excel

New England Journal of Medicine Publishes Studies of VELCADE(R) (bortezomib) for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis

Export this record

Export record to excel

New England Journal of Medicine Publishes Studies of VELCADE for Injection in Multiple Myeloma and MLN02 in Ulcerative Colitis

Export this record

Export record to excel

In Phase II Study, Millennium Investigational Drug MLN02 Produced Significant Improvement in Ulcerative Colitis Remission Rates as Compared to Placebo; -- Novel Monoclonal Antibody Was Well Tolerated...

Export this record

Export record to excel

Treatment of Ulcerative Colitis with a Humanized Antibody to the α4β7 Integrin

Export this record

Export record to excel

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

Export this record

Export record to excel

Treatment of Ulcerative Colitis with a Humanized Antibody to the [alpha]^sub 4^[beta]^sub 7^ Integrin

Export this record

Export record to excel

Treatment of Ulcerative Colitis with a Humanized Antibody to the alpha sub(4) beta sub(7) Integrin

Export this record

Export record to excel

Long-term clinical experience with Vedolizumab in patients with mild to moderate Ulcerative Colitis

Export this record

Export record to excel

Advances in biologic therapy for ulcerative colitis and Crohn's disease

Export this record

Export record to excel

Exclusive antagonism of the [alpha]4[beta]7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates

Export this record

Export record to excel

Antibody to [alpha]^sub 4^[beta]^sub 7^ Integrin for Ulcerative Colitis/THE AUTHORS AND A COLLEAGUE REPLY

Export this record

Export record to excel

Evolving knowledge and therapy of inflammatory bowel disease

Export this record

Export record to excel

Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers

Export this record

Export record to excel

Internalization of the vedolizumab/α4β7 complex and kinetics of restoring functional activity

Export this record

Export record to excel

Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers: P-136

Refine your search